The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line. 1988

Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
Department of Obstetrics and Gynecology, National Defense Medical College, Saitama.

The present study was designed to elucidate the mechanism of resistance to cisplatin. A cisplatin-resistant cell line (KFr) was established from KF cells derived from human serous cystadenocarcinoma of the ovary. The DNA histogram revealed an increase of S-phase cells and a decrease of G1-phase cells in cultured KFr cells, compared to that in cultured KF cells. Although the cisplatin content in the KF cells incubated with cisplatin at 10 micrograms/ml increased in a time-dependent manner, that in the KFr cells remained unchanged during the experimental period. When 0.5 mg of cisplatin was administered ip to nude mice with KF or KFr tumor, the cisplatin content in the KFr tumor was significantly lower than that in the KF tumor. The KFr cells showed a cross-resistance to L-phenylalanine mustard, while no cross-resistance to vincristine or 5-fluorouracil was observed. These findings suggest that the mechanism of cisplatin resistance in the KFr cells involves a decrease of cisplatin accumulation in the tumor cells.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine

Related Publications

Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
January 1992, Cancer research,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
July 1992, International journal of oncology,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
September 1996, Zhonghua yi xue za zhi,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
March 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
July 1997, International journal of cancer,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
May 1995, International journal of cancer,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
December 1986, Journal of the National Cancer Institute,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
June 1993, Human cell,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
January 2012, PloS one,
Y Kikuchi, and I Iwano, and M Miyauchi, and T Kita, and K Oomori, and I Kizawa, and M Sugita, and Y Tenjin
March 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!